bsi compact

  • Product development / formulation (cosmetics, skin care, hair care, hygiene, medical device and more)
  • Product conception
  • Scale-up and support, production
  • Stability tests, challenge tests
  • Regulatory support (PIF, CPNP, safety assessment)
  • Raw material distribution and consulting
  • Technical consulting

More than 20 years experience. For other inquiries, please contact us.

 

Article

  1. Wölfle U. * ID , Haarhaus B. , Seiwerth J.,  Cawelius A., Schwabe K., Quirin K-W,  Schempp C. M., The Herbal Bitter Drug Gentiana lutea Modulates Lipid Synthesis in Human Keratinocytes In Vitro and In Vivo, Int. J. Mol. Sci. 2017
  2. Schwabe K., Logistik vom Feinsten - Ausgeklügelte Trägersysteme sorgen dafür, dass Wirkstoffe in Pflegeprodukten genau in jene Hautbereiche gelangen wo sie Alterungsprozesse effektiv verzögern können.,  medical BEAUTY FORUM 2015 (1), 12-17
  3. Schwabe M., Rey L., Woresana®: un actif biotechnologique pour des cosmétiques de pointe / Biotechnological active for advanced skincare, Expression Cosmétique, 2014 (12), 261-265   
  4. Wolf G., Schwabe M., Wolf M., Schwabe K., Lactobacillus Rye Flour Ferment/Filtrate – Nachhaltige probiotische Wirkstoffkomplexe für die moderne Hautpflege,  SÖFW-Journal, 20014 (3), 140, 2-9
  5. Keck C.M., Müller R.H., Schwabe K., Anantaworasakul P., Patel M., Okonogi S., Singh K. K., Roessner D., Scherres R., Silver-nanolipid-complex- A new concept for the treatment of atopic dermatitis, Int. J. of Pharmaceutics, 2, 462 (2014), 44– 51
  6. Schwabe K., ECM Complex- Der Haut Architekt, Medical Beauty – Das dermo-kosmetische Fachmagazin, 2013 (4), 4-5
  7. Schwabe K.,  Spannende Zeiten – Trends in der Wirkstoffforschung, Medical Beauty – Das dermo-kosmetische Fachmagazin, 2013 (1), 9
  8. Schwabe K., Niggemann O. Hommoss A., Ceraparts® - In vivo efficacy via physical skin care, SÖFW-Journal, 20012 (10), 138, 10-17
  9. Schwabe K., Rimpler C., “Frei von- Produkte“ - Moderne Emulsionen und wie Sie wirken. Kosmetik und Pflege, 2012 (3), 32-33
  10. Schwabe K., Niggemann O., Active ingredients for physical skin care, COSSMA, 2012, 5, 10-12
  11. Obaidat, W. Schwabe, K. Müller, R. H., Keck, C. M., Preservation of nanostructured lipid carriers (NLC)  Eur. J. Pharm. Biopharm., 2010 (9), 76 (1), 56-57 
  12. Padeike, J., Schwabe, K., Müller, R. H., Influence of nanostructured lipid carriers (NLC) on the physical properties of the Cutanova Nanorepair Q10 cream and the in vivo skin hydration effect, Int. J. of Pharmaceutics, 2010 (8), 386, 1-2, 166-173
  13. Keck, C. M., Schwabe K.. Silver-Nanolipid complex for application to atopic dermatitis skin rheological characterization, in vivo efficiency & theory of action, J. Biomed. Nanotechnol., 2009 (8),  5 (4), 428-436
  14. Schwabe, K., NLC (Nanostructured Lipid Carrier) more than just a cariersystem, Eurocosmetics, 2010, 6, 9-28
  15. Müller, R. H., Hommoss, A., Schwabe, K., Lipophiler Wirkstofftransport durch NLC-Technologie, Euro Cosmetics, 2005, 11/12, 2-5
  16. Müller, R. H., Petersen, R., Hommoss, A., Schwabe, K., A new dimension in cosmetic products by nanostructured lipid carriers (NLC) technology, Euro Cosmetics, 2007, 3, 32-37

Patents 

  1. Schwabe, K., Keck, C. M., Rimpler C. (2008) Lipid Nanoparticles for the Enhancement of the dermal action of solid particles, European Patent Application No. 08 019 306.3, 4 Nov. 2008.
  2. Schwabe K., Dr. Rimpler GmbH, Ceraparts® a novel lipidnanoparticle carrier system for topical application

Proceedings

  1. Schwabe, K., Müller, R. H., Hommoss, A., Nanorepair Q10 – First dermal product on the market based on nanostructured lipid carrier (NLC) technology, proceeding in the 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Geneva, March 27-30, 2006
  2. K. Schwabe and C.M. Keck (2009). Microsilver-NLC complexes – a novel formulation principle for the treatment of atopic eczema, Controlled Release Society German Chapter Annual Meeting 2009, March 19-20, Halle/Germany, O14.

Abstracts

  1. Wölfle Ute, Schempp Christoph M., Schwabe K., Die Bitterstoffrezeptoren (TAS2R) der Epidermis, DDG (Deutsche Dermatologische Gesellschaft)  KOMPAKT & PRAXISNAH, 2.-3. März, Stuttgart/Germany, 2018
  2. Schwabe K., Niggemann O., Hommoss A.,Lingen K., Ceraparts® - A new dimension of Skin Care, SEPAWA Congress, Fulda/ Germany 2012
  3. Schwabe, K., Keck C.M., Industrial scaling up of nanostructured lipid carrier (NLC) production using reverse flow chamber technology. Annual Meeting of the German Pharmaceutical Society (DPhG), Jena/Germany, 2009
  4. Schwabe, K. and Keck, C. M., Combination of Nanostructured Lipid Carriers (NLC) and Microsilver - novel concept for atopic dermatitis, 2nd Pharmaceutical Siences Fair & Exhibition (PharmSciFair), 8-12 June, Nice/France, 2009
  5. Schwabe, K. and Keck C. M., (2009). Silver-nanolipid formulation for skin care in atopic dermatitis. 5th German-Polish Symposium "New Challenges for Pharmaceutical Sciences", 15 May, Poznan/Poland
  6. Hommoss, A., Schwabe, K., Müller, R. H., Nanostructured lipid carrier (NLC) in cosmetic dermal formulations, abstract in the 7th European Workshop on Particulate Systems (EWPS), Berlin, May 30-31, 2008
  7. Schwabe, K., Keck, C.M., Microsilver NLC complex for the treatment of atopic eczema, in Controlled Release  Society German Chapter Annual Meeting, 2009 Halle/Saale, March 19-20.
  8. Müller, R. H., Hommoss, A., Schwabe, K., Rimpler, M., Dermal coenzyme Q10
    formulations based on nanostructured lipid carrier (NLC), abstract in the Annual Meeting of the American Association of Pharmaceutical Scientists (AAPS), San Antonio, USA, No. M1269, October 29 - November 2, 2006
  9. Müller, R. H., Hommoss, A., Schwabe, K., Lipid Nanoparticles (SLN, NLC) – Present state of development for dermal delivery, abstract in the European Workshop on Particulate Systems (EWPS), Geneva, March 23-25, 2006